Stanisławowski, M., Wiśniewski, P., Guzek, M., Wierzbicki, P. M., Adrych, K., Smoczyński, M., . . . Kmieć, Z. (2014). Influence of receptor activator of nuclear factor kappa B ligand, osteoprotegerin and interleukin-33 on bone metabolism in patients with long-standing ulcerative colitis. Journal of Crohn's & Colitis, 8(8), 802. https://doi.org/10.1016/j.crohns.2013.12.021
Chicago Style (17th ed.) CitationStanisławowski, M., P. Wiśniewski, M. Guzek, P. M. Wierzbicki, K. Adrych, M. Smoczyński, K. Sworczak, K. Celiński, and Z. Kmieć. "Influence of Receptor Activator of Nuclear Factor Kappa B Ligand, Osteoprotegerin and Interleukin-33 on Bone Metabolism in Patients with Long-standing Ulcerative Colitis." Journal of Crohn's & Colitis 8, no. 8 (2014): 802. https://doi.org/10.1016/j.crohns.2013.12.021.
MLA (9th ed.) CitationStanisławowski, M., et al. "Influence of Receptor Activator of Nuclear Factor Kappa B Ligand, Osteoprotegerin and Interleukin-33 on Bone Metabolism in Patients with Long-standing Ulcerative Colitis." Journal of Crohn's & Colitis, vol. 8, no. 8, 2014, p. 802, https://doi.org/10.1016/j.crohns.2013.12.021.